Gebäude Außenansicht Dr. Seibt Genomics und Beta Klinik 02

Dr. rer. nat. Dipl.- Pharm. Benjamin Seibt

CEO / Pharmacist and Researcher

Benjamin Seibt studied pharmacy in Bonn for his state exams and diploma, earned his doctorate funded by a scholarship in pharmaceutical chemistry, and in parallel completed his training as a "Specialist pharmacist for drug information". As part of his doctorate he worked at the University of Barcelona (Spain) and the Max Planck Institute in Göttingen.

He presented scientific posters and gave presentations at national and international conferences, e.g. in the Netherlands, Austria, Spain, Australia and Japan. Benjamin Seibt works voluntarily on the executive board of the North Rhine Chamber of Pharmacists (deputy). After completing his doctorate, he backpacked around the world and on the way met many native people on every continent. Afterwards, he worked as a post-doctoral fellow in Australia at the University of Melbourne for the St. Vincent's Hospital in Melbourne.

Benjamin Seibt was the winner of the Bayer Promotion Prize in 2013. In 2014, he received the "Young Investigator Award" in Canberra (Australia) from the "Transplantation Society of Australia and New Zealand" for his scientific achievements.

Since 2013 he has been building up the company Dr. Seibt Genomics in Bonn which he ultimately founded in 2014. Benjamin Seibt worked in parallel from 01/2015 to 12/2016 as an emergency pharmacist at St. Martin Pharmacy in Bad Honnef and at the Maltese School in Bonn. He has also been a lecturer at the Rhein University of Applied Sciences in Cologne since 2014 and, since 2016, a member of the supervisory board (deputy) of the Pension Fund for the North Rhine Chamber of Pharmacists. For the purposes of establishing business relations for Dr. Seibt Genomics, he also traveled in business delegations with the Federal Ministry of Economic Affairs and Energy to Oman, Qatar and Croatia. In 2017, Dr. Seibt Genomics, together with 9 European universities / institutions and 8 other industrial partners, was awarded the coveted Marie-Skłodowska-Curie Grant under the Horizon 2020 program of the European Commission.

Jump to top